Orchard: A Biomarker-Directed Phase 2 Platform Study In Pts With Advanced Egfrm Nsclc Progressing On First-Line Osimertinib

JOURNAL OF THORACIC ONCOLOGY(2021)

Cited 4|Views13
No score
Key words
osimertinib, non-small cell lung cancer, resistance
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined